Home » Topics » Regulatory » Patents

Patents
RSS

Novel Raf kinase B inhibitors claimed by Wyeth

April 21, 2009

Factor VIIa inhibitors presented by Eisai for the treatment of thrombotic disorders

April 20, 2009

Bayer claims novel compounds for the treatment of dyslipidemia

April 20, 2009

Muscarinic M3 antagonists described by Pfizer for the treatment of COPD and asthma

April 20, 2009

GSK reports novel glycine transporter inhibitors for schizophrenia treatment

April 20, 2009

Novel Janus kinase 2 inhibitors disclosed by Merck & Co.

April 20, 2009

AstraZeneca claims novel phthalazinone derivatives for cancer treatment

April 20, 2009

Novel beta2-adrenoceptor agonists described by Sepracor for the treatment of bronchoconstriction

April 17, 2009

Jenrin Discovery claims novel cannabinoid receptor antagonists

April 17, 2009

Novel compounds for the treatment of hepatitis C claimed by Abbott

April 17, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...